Beckton Dickinson Partners With U.S. Government to Make Injection Devices
July 08 2020 - 6:50AM
Dow Jones News
By Dave Sebastian
Beckton Dickinson and Co. said it has entered a public-private
partnership with the U.S. government for a $70 million project to
make injection devices needed for Covid-19 vaccines.
The company said the Biomedical Advanced Research and
Development Authority will invest about $42 million into the
project to expand BD's operations and manufacturing capacity in
Nebraska. The agency would then have priority access to injection
devices, such as syringes and needles, needed for mass vaccination
efforts for Covid-19 and future pandemics, BD said.
BD said it has finalized the first order for 50 million needles
and syringes to be delivered by the end of December for the
government's Covid-19 vaccination effort. It said it will work with
the government to finalize additional quantities needed to support
Operation Warp Speed, a government program that aims to provide
Covid-19 vaccines by January.
The company said it doesn't expect orders in the partnership to
affect its ability to fulfill existing requirements for usual
injections such as flu vaccines and childhood immunizations. It
also said it seeks priority access to raw materials under the
Defense Production Act.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
July 08, 2020 07:35 ET (11:35 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2024 to May 2024
Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From May 2023 to May 2024